Scyliorhinus canicula chromosome 30, sScyCan1.1, whole genome shotgun sequence.
Scyliorhinus canicula (smaller spotted catshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Carcharhiniformes; Scyliorhinidae; Scyliorhinus.
REFSEQ INFORMATION: The reference sequence is identical to\nLR744059.1.\nAssembly name: sScyCan1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the SC on 2020/12/17. The\noriginal whole-genome shotgun project has the accession\nCACTIT000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Scyliorhinus canicula Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.5\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
immunoglobulin kappa light chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
immunoglobulin kappa light chain-like isoform X1
immunoglobulin kappa light chain-like, transcript variant X2
immunoglobulin kappa light chain-like isoform X2
uncharacterized LOC119958579, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC119958579, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC119958579 isoform X2
uncharacterized protein LOC119958579 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
immunoglobulin kappa light chain-like, transcript variant X3
immunoglobulin kappa light chain-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 183 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
39S ribosomal protein L30, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 48% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC119958660, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119958660, transcript variant X1
uncharacterized LOC119958660, transcript variant X3
uncharacterized protein LOC119958660 isoform X2
uncharacterized protein LOC119958660 isoform X1
uncharacterized protein LOC119958660 isoform X3
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein-like, transcript variant X1
phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein-like, transcript variant X2
uncharacterized protein LOC119958673 isoform X2
uncharacterized protein LOC119958673 isoform X1
phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein-like, transcript variant X3
phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein-like isoform X3
Ig heavy chain C region-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
immunoglobulin superfamily member 1-like, transcript variant X2
immunoglobulin superfamily member 1-like, transcript variant X3
immunoglobulin superfamily member 1-like, transcript variant X4
immunoglobulin superfamily member 1-like, transcript variant X1
immunoglobulin superfamily member 1-like, transcript variant X5
immunoglobulin superfamily member 1-like isoform X1
immunoglobulin superfamily member 1-like isoform X3
immunoglobulin superfamily member 1-like isoform X2
Ig gamma-2A chain C region-like, transcript variant X6
Ig gamma-2A chain C region-like isoform X6
immunoglobulin lambda-1 light chain-like
uncharacterized LOC119958657, transcript variant X2
uncharacterized LOC119958657, transcript variant X3
uncharacterized LOC119958657, transcript variant X1
uncharacterized protein LOC119958657 isoform X2
uncharacterized protein LOC119958657 isoform X3
uncharacterized protein LOC119958657 isoform X1
uncharacterized LOC119958659, transcript variant X2
uncharacterized LOC119958659, transcript variant X1
immunoglobulin kappa light chain-like, transcript variant X5
immunoglobulin kappa light chain-like isoform X5
immunoglobulin kappa light chain-like, transcript variant X4
immunoglobulin kappa light chain-like isoform X4
transfer RNA isoleucine (anticodon GAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon AAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC119958685, transcript variant X7
uncharacterized LOC119958685, transcript variant X1
uncharacterized LOC119958685, transcript variant X2
uncharacterized LOC119958685, transcript variant X6
uncharacterized LOC119958685, transcript variant X8
uncharacterized LOC119958685, transcript variant X3
uncharacterized LOC119958685, transcript variant X10
uncharacterized LOC119958685, transcript variant X4
uncharacterized LOC119958685, transcript variant X5
uncharacterized LOC119958685, transcript variant X13
uncharacterized LOC119958685, transcript variant X12
uncharacterized LOC119958685, transcript variant X9
uncharacterized LOC119958685, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X3
NAD(P)HX epimerase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
NAD(P)HX epimerase, transcript variant X7
ras GTPase-activating-like protein IQGAP1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ras GTPase-activating-like protein IQGAP1
tripartite motif-containing protein 46-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
ribosomal RNA adenine dimethylase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
interferon-stimulated 20 kDa exonuclease-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
phospholipase A and acyltransferase 3-like, transcript variant X1
phospholipase A and acyltransferase 3-like, transcript variant X2
phospholipase A and acyltransferase 3-like isoform X2
phospholipase A and acyltransferase 3-like isoform X1
dolichyl-phosphate mannosyltransferase subunit 3, regulatory
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dolichol-phosphate mannosyltransferase subunit 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized protein PFB0765w-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein PFB0765w-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized protein PFB0765w-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
regulatory factor X, 5, transcript variant X2
regulatory factor X, 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
pogo transposable element derived with ZNF domain b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
MLLT11 transcription factor 7 cofactor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MLLT11 transcription factor 7 cofactor, transcript variant X3
MLLT11 transcription factor 7 cofactor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
GA-binding protein subunit beta-1-like, transcript variant X1
GA-binding protein subunit beta-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
GA-binding protein subunit beta-1-like isoform X1
GA-binding protein subunit beta-1-like isoform X2
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
translocon-associated protein subunit beta
chaperonin containing TCP1, subunit 3 (gamma)
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: T-complex protein 1 subunit gamma
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SMG5 nonsense mediated mRNA decay factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
disintegrin and metalloproteinase domain-containing protein 12
vegetative cell wall protein gp1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vegetative cell wall protein gp1-like, transcript variant X3
vegetative cell wall protein gp1-like, transcript variant X1
vegetative cell wall protein gp1-like isoform X1
vegetative cell wall protein gp1-like isoform X3
vegetative cell wall protein gp1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor, alpha-induced protein 8-like 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tumor necrosis factor, alpha-induced protein 8-like 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tumor necrosis factor, alpha-induced protein 8-like protein 2 B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator-like
mothers against decapentaplegic homolog 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L9, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
induced myeloid leukemia cell differentiation protein Mcl-1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
hyaluronan and proteoglycan link protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
LOW QUALITY PROTEIN: relaxin-3 receptor 2-like
regulation of nuclear pre-mRNA domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
regulation of nuclear pre-mRNA domain-containing protein 2-like isoform X1
regulation of nuclear pre-mRNA domain-containing protein 2-like isoform X2
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
small conductance calcium-activated potassium channel protein 3
neuronal acetylcholine receptor subunit beta-2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 119 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
neuronal acetylcholine receptor subunit beta-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 119 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neuronal acetylcholine receptor subunit beta-2-like isoform X2
neuronal acetylcholine receptor subunit beta-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 119 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neuronal acetylcholine receptor subunit beta-2-like isoform X1
neuronal acetylcholine receptor subunit beta-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neuronal acetylcholine receptor subunit beta-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
neuronal acetylcholine receptor subunit beta-2-like isoform X3
double-stranded RNA-specific adenosine deaminase
SH2 domain-containing adapter protein E-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
atrial natriuretic peptide receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
interleukin enhancer-binding factor 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
misato mitochondrial distribution and morphology regulator 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
death associated protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
death associated protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
death associated protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
28S ribosomal protein S29, mitochondrial isoform X3
28S ribosomal protein S29, mitochondrial isoform X1
28S ribosomal protein S29, mitochondrial isoform X2
ash1 (absent, small, or homeotic)-like (Drosophila)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
histone-lysine N-methyltransferase ASH1L
secretory carrier membrane protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
secretory carrier-associated membrane protein 3 isoform X1
secretory carrier membrane protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
secretory carrier-associated membrane protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
CDC-like kinase 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
CDC-like kinase 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
dual specificity protein kinase CLK2 isoform X2
dual specificity protein kinase CLK2 isoform X1
CDC-like kinase 2a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
dual specificity protein kinase CLK2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
KH homology domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
CREB-regulated transcription coactivator 2-like
synaptic vesicle glycoprotein 2A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
synaptic vesicle glycoprotein 2A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
synaptic vesicle glycoprotein 2A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and death domain-containing protein 1A-like
serine/arginine repetitive matrix protein 2-like, transcript variant X49
serine/arginine repetitive matrix protein 2-like, transcript variant X45
serine/arginine repetitive matrix protein 2-like, transcript variant X41
serine/arginine repetitive matrix protein 2-like, transcript variant X33
serine/arginine repetitive matrix protein 2-like, transcript variant X34
serine/arginine repetitive matrix protein 2-like, transcript variant X38
serine/arginine repetitive matrix protein 2-like, transcript variant X29
serine/arginine repetitive matrix protein 2-like, transcript variant X35
serine/arginine repetitive matrix protein 2-like, transcript variant X9
serine/arginine repetitive matrix protein 2-like, transcript variant X30
serine/arginine repetitive matrix protein 2-like, transcript variant X11
serine/arginine repetitive matrix protein 2-like, transcript variant X10
serine/arginine repetitive matrix protein 2-like, transcript variant X39
serine/arginine repetitive matrix protein 2-like, transcript variant X43
serine/arginine repetitive matrix protein 2-like, transcript variant X20
serine/arginine repetitive matrix protein 2-like, transcript variant X12
serine/arginine repetitive matrix protein 2-like, transcript variant X47
serine/arginine repetitive matrix protein 2-like, transcript variant X16
serine/arginine repetitive matrix protein 2-like, transcript variant X46
serine/arginine repetitive matrix protein 2-like, transcript variant X40
serine/arginine repetitive matrix protein 2-like, transcript variant X36
serine/arginine repetitive matrix protein 2-like, transcript variant X18
serine/arginine repetitive matrix protein 2-like, transcript variant X37
serine/arginine repetitive matrix protein 2-like, transcript variant X24
serine/arginine repetitive matrix protein 2-like, transcript variant X31
serine/arginine repetitive matrix protein 2-like, transcript variant X25
serine/arginine repetitive matrix protein 2-like, transcript variant X8
serine/arginine repetitive matrix protein 2-like, transcript variant X42
serine/arginine repetitive matrix protein 2-like, transcript variant X26
serine/arginine repetitive matrix protein 2-like, transcript variant X17
serine/arginine repetitive matrix protein 2-like, transcript variant X44
serine/arginine repetitive matrix protein 2-like, transcript variant X32
serine/arginine repetitive matrix protein 2-like, transcript variant X28
serine/arginine repetitive matrix protein 2-like, transcript variant X27
serine/arginine repetitive matrix protein 2-like, transcript variant X19
serine/arginine repetitive matrix protein 2-like, transcript variant X3
serine/arginine repetitive matrix protein 2-like, transcript variant X2
serine/arginine repetitive matrix protein 2-like, transcript variant X22
serine/arginine repetitive matrix protein 2-like, transcript variant X14
serine/arginine repetitive matrix protein 2-like, transcript variant X13
serine/arginine repetitive matrix protein 2-like, transcript variant X4
serine/arginine repetitive matrix protein 2-like, transcript variant X6
serine/arginine repetitive matrix protein 2-like, transcript variant X5
serine/arginine repetitive matrix protein 2-like, transcript variant X23
serine/arginine repetitive matrix protein 2-like, transcript variant X15
serine/arginine repetitive matrix protein 2-like, transcript variant X7
serine/arginine repetitive matrix protein 2-like, transcript variant X21
serine/arginine repetitive matrix protein 2-like, transcript variant X1
serine/arginine repetitive matrix protein 2-like, transcript variant X48
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X44
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like isoform X38
serine/arginine repetitive matrix protein 2-like isoform X49
acidic leucine-rich nuclear phosphoprotein 32 family member E-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
polymerase (RNA) III (DNA directed) polypeptide C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
polymerase (RNA) III (DNA directed) polypeptide C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC3
uncharacterized threonine-rich GPI-anchored glycoprotein PJ4664.02-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mothers against decapentaplegic homolog 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mothers against decapentaplegic homolog 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mothers against decapentaplegic homolog 4-like isoform X2
mothers against decapentaplegic homolog 4-like isoform X1
chromatin target of PRMT1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
chromatin target of PRMT1a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
chromatin target of PRMT1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
chromatin target of PRMT1a, transcript variant X1
uncharacterized LOC119958677, transcript variant X1
uncharacterized LOC119958677, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: lysosomal acid glucosylceramidase